Mrs. Marie Ann Sweeney, APRN Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 883 Paddock Ave, Meriden, CT 06450 Phone: 203-630-5248 |
Michelle Sara Gauthier, APRN Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Accepting Medicare Assignments Practice Location: 134 State St, Meriden, CT 06450 Phone: 203-237-2229 Fax: 203-686-1677 |
Miss Diane H Puppolo, APRN Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 883 Paddock Ave, Meriden, CT 06450 Phone: 203-630-5314 |
News Archive
The European Society of Coloproctologists has revealed that almost 1500 clinicians from around the world (49 countries) have participated in its latest cohort study recording and sharing the results of 5640 operations – marking one of the largest studies of its kind.
Health care reform will impact every American in some way. The question is how and when? The healthychat.com website was created to address the many questions consumers have about health insurance. Since its launch on May 1, thousands have viewed healthychat.com, creating a community forum addressing myriad health care questions.
When seizures strike, the most immediate goal for caregivers is to get appropriate medication to the patient as quickly as possible to stop the seizing activity. In a paper published in the June Academic Emergency Medicine, UC emergency medicine assistant professor Jason McMullan, MD, found that the best means of stopping status epilepticus may be with the least direct medication.
A new analysis indicates that the US opioid epidemic likely applies to the unique population of dialysis patients. The study, which appears in an upcoming issue of the Journal of the American Society of Nephrology, also found links between higher opioid drug prescription and increased risks of dialysis discontinuation, hospitalization, and early death.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
› Verified 6 days ago